WASHINGTON, Sept 27 (Reuters) - The Federal Trade Commission said on Thursday it approved Mylan Laboratories Inc’s (MYL.N: Quote, Profile, Research) acquisition of Merck KGaA’s (MRCG.DE: Quote, Profile, Research) generics unit after the companies agreed to divest five drugs.
